Podcasts

#4 – Psilocybin Incorporated

The crew recaps the Economic Models for the Expansion of Psychedelics panel at the Horizons Perspectives on Psychedelics conference in New York. They also discuss the corrosive effects that Compass Pathways, a for-profit psilocybin startup has had in psychedelic science and research.

Apple
Podcasts
Google Play
Spotify
Stitcher
Radio Public
Deezer
RSS
The crew recaps the Economic Models for the Expansion of Psychedelics panel at the Horizons Perspectives on Psychedelics conference in New York. They also discuss the corrosive effects that Compass Pathways, a for-profit psilocybin startup has had in psychedelic science and research.

Co-hosts: Brian Normand, Neşe Devenot, David Nickles, Brian Pace. Editor: Matt Payne.

Watch

Hamilton’s Pharma Cope, Part 4: “The Face of Psychedelic Journalistic Ethics” Transcript

In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.

Hamilton’s Pharma Cope, Part 3: Paid Protestor Paranoia Transcript

In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.

Hamilton’s Pharma Cope, Part 2: Psychedelic Cult Defenders Transcript

In this episode, we examine previous smear campaigns against us related to our reporting on the Church of Psilomethoxin and Martin Ball, as well as false claims about who funds us and why.

Hamilton’s Pharma Cope, Part 1: “DEA Informants” Transcript

In this episode, we respond to Hamilton Morris’ claims that we are DEA informants and that we colluded with the FDA to get Lykos Therapeutics’ MDMA therapy application rejected.

Watch

Read more

Hamilton’s Pharma Cope, Part 4: “The Face of Psychedelic Journalistic Ethics” Transcript

Hamilton’s Pharma Cope, Part 3: Paid Protestor Paranoia Transcript

Hamilton’s Pharma Cope, Part 2: Psychedelic Cult Defenders Transcript

Hamilton’s Pharma Cope, Part 1: “DEA Informants” Transcript